Cancer cells often develop mechanisms to evade mitotic catastrophe, such as overexpressing mitotic checkpoint proteins or inactivating apoptotic pathways. This ability to circumvent cell death contributes to the survival and persistence of cancer cells, even under therapeutic stress. Research into these evasion strategies is ongoing, with the goal of identifying new targets for cancer treatment.
